# China Hip Implants Market > China Hip Implants Market Research Report By Product Type (Total Hip Replacement Implants, Fixed-Bearing Hip Implants, Mobile-Bearing Total Hip Implants, Partial Hip Replacement Implants, Hip Resurfacing Implants, Revision Hip Replacement Implants), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers) andBy Material (Metal-on-Polyethylene, Ceramic-on-Metal, Metal-on-Metal, Ceramic-on-Polyethylene, Ceramic-on-Ceramic) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 3.5% - **2024:** $ 763.35 Million - **2025:** $ 790.07 Million - **2035:** $ 1,115 Million - **Key Players:** Johnson & Johnson (US), Stryker Corporation (US), Zimmer Biomet (US), Smith & Nephew (GB), Medtronic (US), DePuy Synthes (US), B. Braun Melsungen AG (DE), Exactech (US), Wright Medical Group N.V. (NL) **Report ID:** MRFR/MED/49365-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/china-hip-implants-market-51122 --- ## Market Summary ## **China Hip Implants Market Overview** As per MRFR analysis, the China Hip Implants Market Size was estimated at 737.4 (USD Million) in 2023.The China Hip Implants Market Industry is expected to grow from 763.5(USD Million) in 2024 to 1,140 (USD Million) by 2035. The China Hip Implants Market CAGR (growth rate) is expected to be around 3.711% during the forecast period (2025 - 2035). ## **Key China Hip Implants Market Trends Highlighted** In the China Hip Implants Market, several key market drivers are shaping the landscape. The increasing prevalence of hip-related disorders due to an aging population is a significant factor. As the median age in China continues to rise, the demand for hip implants is expected to increase, driven by the need for treatments related to osteoarthritis and fractures. Additionally, advancements in medical technology and materials are enhancing the quality and lifespan of hip implants, making them more appealing to both healthcare providers and patients. The government’s focus on improving healthcare infrastructure and expanding access to orthopedic surgeries further boosts the market potential in China. Potential opportunities related to the fast-evolving trend concerning minimally invasive operations which have more benefits, include shorter recovery times and enhanced results. There is also increasing demand for specialized and tailored implants that suit the contours of the bone, which can improve the efficacy of the surgeries. Prospects for innovation and marketing of hip implants in the region might further improve with greater partnerships with local and foreign businesses. In the recent past, there has been a change in the educational awareness of the patients concerning the hip. Campaigns aimed at informing the public about the benefits of early intervention for hip issues are gaining traction, prompting more individuals to seek treatment sooner. This aligns with the government’s initiative to promote healthier lifestyles. As Chinese society becomes more health-conscious, the acceptance of hip replacement surgeries is increasing, supporting the overall trend of medical advancement in this sector. The combination of these factors indicates a burgeoning market poised for growth. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **China Hip Implants Market Drivers** ### Increasing Aging Population The aging population in China is one of the most significant drivers for growth in the China Hip Implants Market Industry. According to the National Bureau of Statistics of China, the population aged 60 and above reached approximately 267 million in 2022, accounting for around 19% of the total population. This demographic is predicted to grow significantly, with estimates suggesting that by 2035, the elderly population will surpass 400 million. A higher prevalence of hip fractures and osteoarthritis among the elderly necessitates a greater demand for hip implant surgeries, propelling the market forward.The Ministry of Health has recognized this trend, thereby increasing funding towards orthopedic healthcare services, thus creating a conducive environment for the expansion of the China Hip Implants Market. ### Advancements in Medical Technology Technological advancements in the field of orthopedic implants significantly influence the China Hip Implants Market Industry. With innovations such as minimally invasive surgical techniques and improved materials for hip implants, patient outcomes have drastically improved. For instance, the introduction of titanium and ceramic materials offers higher durability and lowers the risk of infection. The China Food and Drug Administration has been actively involved in speeding up the approval process for innovative implants, highlighting a commitment to modernizing the healthcare landscape.The continuous investment in Research and Development by domestic manufacturers fosters an environment conducive to growth in this sector. ### Rising Healthcare Expenditure China's healthcare expenditure has seen a consistent increase over the past decade, which serves as a vital driver for the China Hip Implants Market Industry. According to the National Health Commission, healthcare spending is projected to reach around 7.5% of the GDP by 2025, compared to 5.3% in 2020. This financial commitment reflects the government's emphasis on improving healthcare services, including orthopedic surgeries. The public's growing awareness of advancements in orthopedic care leads to higher patient inflow into hospitals for elective surgeries such as hip implant procedures.With increased funding and insurance coverage, patients are more likely to seek out hip implant surgeries, reflecting positively on market growth. ## **China Hip Implants Market Segment Insights** ### **Hip Implants Market Product Type Insights** The China[Hip Implants Market](../../../reports/hip-implants-market-8448) is witnessing notable developments across various product types, which play a crucial role in addressing the diverse orthopedic needs of the population. Among the primary categories, Total Hip Replacement Implants have emerged as a significant option, reflecting the growing prevalence of hip-related issues, especially among the aging population. This demographic trend is increasingly pushing demand for innovative and durable solutions in hip replacement procedures. Fixed-Bearing Hip Implants are another essential category offering stability and reliability, which are critical factors for ensuring patient satisfaction and optimal functional outcomes.  These implants continue to dominate in preference among surgeons due to their simplicity in design and effectiveness in a wide range of patient profiles.Mobile-Bearing Total Hip Implants also contribute strongly to market dynamics, with their unique design providing enhanced mobility and reduced wear rates. The choice of mobile-bearing implants is often driven by the demand for long-term performance in active patients, thus capturing the interest of both patients and healthcare professionals prioritizing longevity in solutions.Further diversifying the marketplace are Partial Hip Replacement Implants, which are gaining traction as they present alternatives for patients with less severe damage. Their targeted approach allows for quicker recovery and reduced surgical risk, making them an attractive option in specific patient groups. Hip Resurfacing Implants represent an innovative solution designed for younger, more active patients who wish to preserve their bone stock while receiving effective treatment for hip disorders. Their growing use signals a shift toward more conservative surgical options tailored to individual patient needs in China.Lastly, Revision Hip Replacement Implants highlight the importance of addressing complications from previous surgeries. As the number of hip replacement procedures rises, the necessity for revision surgeries also increases, creating a consistent demand for reliable revision implant options.  This segment underlines the ongoing advancements in surgical techniques and materials aimed at improving patient outcomes in a challenging post-operative landscape. Overall, the segmentation of the China Hip Implants Market reflects a nuanced approach to meeting the varied needs of patients, driven by factors such as aging demographics, increasing prevalence of orthopedic disorders, and advancements in medical technology, thus ensuring a robust and competitive market landscape. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Hip Implants Market End User Insights** The China Hip Implants Market is driven significantly by the End User segment, which consists of various healthcare facilities such as hospitals, orthopedic clinics, and ambulatory surgical centers. Hospitals hold a major share of the market due to their comprehensive services and advanced technology, allowing for complex hip surgeries and post-operative care. Orthopedic clinics are crucial as they specialize in musculoskeletal issues, providing targeted treatments and follow-up care for patients with hip complications.  Ambulatory surgical centers play an increasing role in China's healthcare landscape, offering cost-effective and efficient outpatient services that are appealing to patients seeking quicker recovery times.The demand for hip implants in these facilities is influenced by an aging population, the increasing prevalence of hip-related disorders, and advances in surgical techniques. Moreover, government initiatives and healthcare reforms in China are promoting better access to orthopedic care, further enhancing the growth potential within this segment.  Each of these End User categories contributes to the overall dynamics and growth of the China Hip Implants Market, focusing on improving patient outcomes and operational efficiencies. ### **Hip Implants Market Material Insights** The Material segment of the China Hip Implants Market plays a crucial role in meeting the needs of an aging population and addressing the rising incidence of hip-related ailments. This domain encompasses various components, including Metal-on-Polyethylene, Ceramic-on-Metal, Metal-on-Metal, Ceramic-on-Polyethylene, and Ceramic-on-Ceramic. Among these, Metal-on-Polyethylene is widely favored due to its cost-effectiveness and the long history of successful clinical outcomes, making it a common choice in many procedures.  Ceramic-on-Metal implants are gaining attention for their reduced wear rates and superior performance, which are critical for younger patients seeking longevity in their implants.On the other hand, Ceramic-on-Ceramic designs are lauded for their excellent wear resistance and low friction, making them suitable for a more active lifestyle. Meanwhile, the Metal-on-Metal configurations are known for their robust strength but have faced scrutiny over safety concerns.  The diversity in the types of materials utilized reflects the broader trends in the China Hip Implants Market, where innovation and advancement in materials science significantly influence patient outcomes and satisfaction. The dynamic landscape of materials used in hip implants highlights an ongoing commitment to improving the quality of care in China’s orthopedic sector. ## **China Hip Implants Market Key Players and Competitive Insights:** The China Hip Implants Market is a dynamic and rapidly evolving sector, driven by increasing incidences of hip-related ailments, an aging population, and advancements in surgical techniques and implant technologies. The market is characterized by the presence of both domestic and international players, which creates a highly competitive landscape. Companies are continuously innovating, expanding their product portfolios, and investing in research and development to meet the growing demand for hip implants. The competitive insights reveal a mix of strategies employed by various companies, including mergers and acquisitions, partnerships, and diversification of offerings to enhance their market position and address the needs of healthcare providers and patients alike. B. Braun Melsungen has established a notable presence in the China Hip Implants Market, with a strong emphasis on high-quality products and customer-centric solutions. The company capitalizes on its extensive experience and expertise in the medical device industry, enabling it to innovate and produce advanced hip implant technologies. B. Braun Melsungen's strengths lie in its robust distribution network within China, which allows it to reach a wide range of healthcare facilities, and its commitment to providing comprehensive support and training for healthcare professionals.  The company’s focus on research and development further enhances its competitiveness as it continues to introduce cutting-edge solutions tailored to local market needs, helping to improve patient outcomes and streamline surgical procedures.Wright Medical Group is another notable player in the China Hip Implants Market, recognized for its innovative orthopedic solutions. The company’s focus on advanced artificial joint technologies, including hip and knee implants, has positioned it well within the competitive landscape. Wright Medical Group’s strengths include its commitment to high-quality manufacturing practices and its strong emphasis on product innovation, which is crucial for meeting the evolving needs of the Chinese healthcare market.  The company has made strategic partnerships to enhance its market reach, and several mergers and acquisitions have further bolstered its operational capabilities and technological advancements in the region. With a diversified product portfolio that includes a range of hip implant systems, Wright Medical Group continues to strengthen its market presence in China while focusing on improving surgical outcomes for patients and enhancing the efficiency of surgical procedures. ## **Key Companies in the China Hip Implants Market Include:** - B. Braun Melsungen - Wright Medical Group - Medtronic - Smith & Nephew - Shanghai Peking University MedTech - Zimmer Biomet - Jinling Medical - Beijing Leader Medical Equipment - **[Stryker Corporation](https://www.stryker.com/us/en/portfolios/orthopaedics/joint-replacement/hip.html)** - Exactech - MicroPort Scientific - Conmed - Johnson & Johnson - Tianjin Aorui Biotechnology ## **China Hip Implants Market Industry Developments** The China Hip Implants Market has recently seen notable developments, particularly with advancements and product launches from key companies like Medtronic and Stryker Corporation. In October 2023, Stryker Corporation introduced a new line of minimally invasive hip implants projected to enhance recovery times for patients. Concurrently, B. Braun Melsungen has been expanding its product offerings in the region, focusing on innovative materials and surgical techniques. Current affairs indicate an increased focus on Research and Development activities among local companies such as Shanghai Peking University MedTech and Jinling Medical, aiming to improve artificial hip joint durability and functionality in the Chinese demographic.  In recent years, market growth has accelerated, witnessing a significant valuation increase due to rising geriatric population demands, with approximately 180 million individuals over 65 in China by 2025, driving the need for hip replacement surgeries. While there have been limited yet impactful mergers and acquisitions in the sector, attention remains on broader market dynamics, fostering competitive advancement among key players like Zimmer Biomet and Johnson and Johnson as they navigate this expanding landscape. ## **China Hip Implants Market Segmentation Insights** ### **Hip Implants Market Product Type****Outlook** - Total Hip Replacement Implants - Fixed-Bearing Hip Implants - Mobile-Bearing Total Hip Implants - Partial Hip Replacement Implants - Hip Resurfacing Implants - Revision Hip Replacement Implants ### **Hip Implants Market End User****Outlook** - Hospitals - Orthopedic Clinics - Ambulatory Surgical Centers ### **Hip Implants Market Material****Outlook** - Metal-on-Polyethylene - Ceramic-on-Metal - Metal-on-Metal - Ceramic-on-Polyethylene - Ceramic-on-Ceramic ## Market Drivers ### Aging Population The aging population in China is a crucial driver for the hip implants market. As the demographic shifts towards an older age group, the incidence of hip-related ailments, such as osteoarthritis and fractures, is likely to increase. Reports indicate that by 2030, approximately 25% of the Chinese population will be over 60 years old. This demographic trend suggests a growing demand for hip implants, as older individuals often require surgical interventions to maintain mobility and quality of life. Consequently, the hip implants market is expected to expand significantly, driven by the need for effective solutions to address age-related hip issues. ### Rising Incidence of Obesity The rising incidence of obesity in China is emerging as a significant driver for the hip implants market. Obesity is closely linked to various musculoskeletal disorders, including hip joint problems. As the prevalence of obesity continues to rise, the demand for hip implants is expected to increase correspondingly. Current estimates suggest that over 30% of the adult population in urban areas is classified as overweight or obese. This trend indicates a potential surge in hip-related surgeries, as individuals with obesity are more likely to require joint replacements. Consequently, the hip implants market may experience substantial growth as healthcare providers address the needs of this demographic. ### Government Initiatives and Support Government initiatives aimed at improving healthcare infrastructure are likely to bolster the hip implants market. In recent years, the Chinese government has implemented policies to enhance access to medical services, particularly in underserved regions. This includes funding for hospitals and clinics to upgrade their facilities and acquire advanced medical technologies. Such initiatives may facilitate greater access to hip implant surgeries, thereby increasing the overall market size. Furthermore, the government's focus on reducing healthcare costs could lead to more affordable options for patients, further driving demand in the hip implants market. ### Increased Awareness of Joint Health There appears to be a rising awareness regarding joint health among the Chinese population, which is positively influencing the hip implants market. Educational campaigns and healthcare initiatives are promoting the importance of early diagnosis and treatment of hip conditions. This heightened awareness may lead to more individuals seeking medical advice and, subsequently, surgical options such as hip implants. As a result, the market could experience a surge in demand, with projections indicating a potential growth rate of around 10% annually over the next five years. This trend underscores the importance of proactive healthcare in driving the hip implants market. ### Technological Innovations in Implant Design Technological innovations in implant design are transforming the hip implants market. Advances in materials science and engineering have led to the development of more durable and biocompatible implants. For instance, the introduction of 3D printing technology allows for customized implants tailored to individual patient anatomy, potentially improving surgical outcomes. These innovations not only enhance the performance of hip implants but also reduce the risk of complications, thereby increasing patient satisfaction. As hospitals and clinics in China adopt these cutting-edge technologies, the market is likely to witness a significant uptick in demand for advanced hip implant solutions. ## Future Outlook The [Hip Implants Market](https://www.marketresearchfuture.com/reports/hip-implants-market-8448) in China is projected to grow at a 3.5% CAGR from 2025 to 2035, driven by an aging population, technological advancements, and increasing healthcare expenditure. **New opportunities:** - Development of biodegradable hip implants for enhanced patient outcomes. - Expansion of telehealth services for post-operative care management. - Investment in AI-driven predictive analytics for personalized implant solutions. By 2035, the hip implants market is expected to achieve substantial growth, reflecting evolving healthcare needs. ## Segment Insights ### By Product: Total Hip Implants (Largest) vs. Revision Hip Implants (Fastest-Growing) In the China hip implants market, Total Hip Implants dominate the segment with the highest market share, characterized by their widespread acceptance and extensive application in total hip replacement procedures. This segment comprises various types of implants, including Fixed-Bearing and Mobile-Bearing variants, contributing significantly to the overall market distribution while maintaining a strong foothold among healthcare providers due to their reliability and clinical success. Revision Hip Implants, on the other hand, represent the fastest-growing segment as an increasing number of patients undergo hip revision surgeries driven by the aging population and previous implant failures. The rise in demand for these specialized implants is fueled by advancements in materials and designs, which enhance longevity and overall performance, thus driving further growth in this area of the market. Total Hip Implants (Dominant) vs. Revision Hip Implants (Emerging) Total Hip Implants are characterized by their robust designs, providing surgeons and patients with reliable options for joint restoration. With established technologies like Fixed-Bearing and Mobile-Bearing designs, this segment remains the backbone of the hip implants market in China, catering to the large patient population requiring total hip replacement due to osteoarthritis and other degenerative conditions. In contrast, Revision Hip Implants are emerging as crucial solutions for addressing complications from previous surgeries. The technological advancements in Revision implants, such as enhanced fixation methods and improved biomaterials, are making them more appealing to orthopedic surgeons and patients alike, thus propelling their rapid growth in the market. ### By End-User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the China hip implants market, Hospitals dominate the end-user segment, capturing a significant share of the overall market due to their capacity to provide comprehensive surgical services and post-operative care. This segment is bolstered by advanced surgical technologies, major capital investment in resources, and a high patient intake of orthopedic surgeries compared to other facilities. On the other hand, Orthopedic Clinics and Ambulatory Surgical Centers are also crucial players, but their market shares are lower, as they cater to specific patient demographics and procedures. The growth trends in the end-user segment are being primarily driven by the increasing incidence of hip disorders and the aging population seeking surgical interventions. Ambulatory Surgical Centers are emerging rapidly due to the shift towards outpatient procedures, offering cost-effective and efficient solutions. Moreover, advancements in minimally invasive surgical techniques are enhancing the attractiveness of orthopedic clinics, making them preferred choices for many patients seeking hip implants, thus contributing to their overall growth in the market. Hospitals (Dominant) vs. Orthopedic Clinics (Emerging) In the China hip implants market, Hospitals hold the dominant position, benefiting from their ability to offer a full suite of services including pre-operative assessments, surgery, and extensive recovery programs under one roof. They also have access to advanced technologies and skilled personnel, making them the go-to option for complex surgeries. In contrast, Orthopedic Clinics are emerging as a viable choice, particularly for non-complex procedures and rehabilitation services. These clinics often provide tailored treatments, fostering a more personalized patient experience. Their growth is propelled by a rising awareness of orthopedic health and a preference for specialized care, which positions them favorably in the evolving landscape of hip implants. ### By Material: Metal-on-Polyethylene (Largest) vs. Ceramic-on-Ceramic (Fastest-Growing) In the China hip implants market, the segment values exhibit a diverse distribution with Metal-on-Polyethylene leading the market share significantly. This segment is favored for its balance of durability and cost-effectiveness, making it a preferred choice among orthopedic surgeons and patients alike. Meanwhile, Ceramic-on-Ceramic is emerging rapidly, attracting attention for its minimal wear and long lifespan, which appeals to younger patients seeking longevity from their implants. Growth trends indicate a shift towards more advanced materials in hip implants, with Ceramic-on-Ceramic notably gaining traction due to its superior biocompatibility and low friction properties. Factors driving this segment include advancements in material science and increased awareness of the benefits of using high-quality materials in orthopedic procedures. The ongoing research and development in hip implant technologies are likely to maintain robust growth in these materials, reflecting evolving healthcare priorities in the region. Metal-on-Polyethylene (Dominant) vs. Ceramic-on-Ceramic (Emerging) Metal-on-Polyethylene remains the dominant segment in the China hip implants market due to its established use, affordability, and reliability in providing effective solutions for hip replacements. This combination makes it the go-to option for many healthcare providers. On the other hand, Ceramic-on-Ceramic is characterized by its increasing popularity in recent years, thanks to advancements that reduce the risk of wear and fracture. This emerging segment is particularly appealing to younger patients who need implants designed for longevity. As manufacturers refine these materials, the gap between these two segments may narrow, highlighting a shift toward greater acceptance of innovative solutions within hip implant offerings. ## Competitive Benchmarking The hip implants market in China is characterized by a dynamic competitive landscape, driven by an increasing aging population and a rising prevalence of orthopedic conditions. Major players such as Johnson & Johnson (US), Stryker Corporation (US), and Zimmer Biomet (US) are actively shaping the market through strategic initiatives focused on innovation and regional expansion. Johnson & Johnson (US) emphasizes its commitment to research and development, aiming to enhance product offerings and improve patient outcomes. Meanwhile, Stryker Corporation (US) is leveraging its technological expertise to introduce advanced surgical solutions, thereby solidifying its market position. Zimmer Biomet (US) appears to be focusing on strategic partnerships to enhance its distribution capabilities, which collectively influences the competitive environment by fostering innovation and improving access to cutting-edge solutions.Key business tactics within the market include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The competitive structure is moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and services, catering to varying consumer needs while also fostering competition among established and emerging companies. In October Johnson & Johnson (US) announced a significant investment in a new manufacturing facility in Shanghai, aimed at increasing production capacity for its hip implant products. This strategic move is likely to enhance supply chain efficiency and reduce lead times, positioning the company to better meet the growing demand in the region. The establishment of this facility underscores Johnson & Johnson's commitment to localizing production and responding to market needs more effectively. In September Stryker Corporation (US) launched a new robotic-assisted surgical system specifically designed for hip replacement procedures. This innovation is expected to improve surgical precision and patient outcomes, thereby reinforcing Stryker's competitive edge in the market. The introduction of this technology aligns with the broader trend of digital transformation in healthcare, indicating Stryker's proactive approach to integrating advanced technologies into its product offerings. In August Zimmer Biomet (US) entered into a strategic partnership with a local Chinese healthcare provider to enhance its distribution network. This collaboration is anticipated to facilitate better access to Zimmer Biomet's products across various regions in China, thereby expanding its market reach. Such partnerships are indicative of a growing trend where companies seek to leverage local expertise to navigate the complexities of the Chinese market more effectively. As of November current competitive trends in the hip implants market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into product development and surgical procedures. Strategic alliances are playing a crucial role in shaping the landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize these areas will be better positioned to thrive in an increasingly competitive environment. ## Recent News & Developments The China Hip Implants Market has recently seen notable developments, particularly with advancements and product launches from key companies like Medtronic and Stryker Corporation. In October 2023, Stryker Corporation introduced a new line of minimally invasive hip implants projected to enhance recovery times for patients. Concurrently, B. Braun Melsungen has been expanding its product offerings in the region, focusing on innovative materials and surgical techniques. Current affairs indicate an increased focus on Research and Development activities among local companies such as Shanghai Peking University MedTech and Jinling Medical, aiming to improve artificial hip joint durability and functionality in the Chinese demographic.  In recent years, market growth has accelerated, witnessing a significant valuation increase due to rising geriatric population demands, with approximately 180 million individuals over 65 in China by 2025, driving the need for hip replacement surgeries. While there have been limited yet impactful mergers and acquisitions in the sector, attention remains on broader market dynamics, fostering competitive advancement among key players like Zimmer Biomet and Johnson and Johnson as they navigate this expanding landscape. ## Report Scope | MARKET SIZE 2024 | 763.35(USD Million) | | --- | --- | | MARKET SIZE 2025 | 790.07(USD Million) | | MARKET SIZE 2035 | 1115.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.5% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Johnson & Johnson (US), Stryker Corporation (US), Zimmer Biomet (US), Smith & Nephew (GB), Medtronic (US), DePuy Synthes (US), B. Braun Melsungen AG (DE), Exactech (US), Wright Medical Group N.V. (NL) | | Segments Covered | Product, End-User, Material | | Key Market Opportunities | Advancements in minimally invasive surgical techniques enhance growth potential in the hip implants market. | | Key Market Dynamics | Rising demand for advanced materials in hip implants drives innovation and competition among manufacturers in the market. | | Countries Covered | China | ## Frequently Asked Questions **Q: What is the current valuation of the hip implants market in China as of 2024?** A: The overall market valuation was $763.35 Million in 2024. **Q: What is the projected market valuation for hip implants in China by 2035?** A: The projected valuation for 2035 is $1,115.0 Million. **Q: What is the expected CAGR for the China hip implants market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during this period is 3.5%. **Q: Which companies are the key players in the China hip implants market?** A: Key players include Johnson & Johnson, Stryker Corporation, Zimmer Biomet, and others. **Q: What were the total hip implants sales figures in 2024?** A: Total hip implants sales figures were between $300.0 Million and $450.0 Million in 2024. **Q: How do the sales of fixed-bearing hip implants compare to mobile-bearing hip implants?** A: Sales for fixed-bearing hip implants ranged from $200.0 Million to $300.0 Million, while mobile-bearing hip implants were between $100.0 Million and $150.0 Million. **Q: What is the market size for partial hip implants in 2024?** A: The market size for partial hip implants was between $80.0 Million and $120.0 Million in 2024. **Q: What segment had the highest sales in the end-user category for hip implants?** A: Hospitals had the highest sales in the end-user category, ranging from $300.0 Million to $450.0 Million. **Q: Which material type for hip implants showed the highest sales figures in 2024?** A: Metal-on-Polyethylene showed the highest sales figures, ranging from $200.0 Million to $290.0 Million. **Q: What is the expected growth trend for the hip implants market in China over the next decade?** A: The market is expected to grow steadily, reaching $1,115.0 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/china-hip-implants-market-51122*